The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
Open accessAbstract
The implementation of the ICH S7B and E14 guidelines has been successful in preventing the introduction of potentially torsadogenic drugs to the market, but it has also unduly constrained drug development by focusing on hERG block and QT prolongation as essential determinants of proarrhythmia risk. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative was established to develop a new paradigm for assessing proarrhythmic risk, building on the emergence of new technologies and an expanded understanding of torsadogenic mechanisms beyond hERG block. An international multi-disciplinary team of regulatory, industry and academic scientists are working together to develop and validate a set of predominantly nonclinical assays and methods that eliminate the need for the thorough-QT study and enable a more precise prediction of clinical proarrhythmia risk. The CiPA effort is led by a Steering Team that provides guidance, expertise and oversight to the various working groups and includes partners from US FDA, HESI, CSRC, SPS, EMA, Health Canada, Japan NIHS, and PMDA. The working groups address the three pillars of CiPA that evaluate drug effects on: 1) human ventricular ionic channel currents in heterologous expression systems, 2) in silico integration of cellular electrophysiologic effects based on ionic current effects, the ion channel effects, and 3) fully integrated biological systems (stem-cell-derived cardiac myocytes and the human ECG). This article provides an update on the progress of the initiative towards its target date of December 2017 for completing validation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
O'Hara, T., Virág, L., Varró, A., & Rudy, Y. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002061 · Cited by 1,196
Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.
January, C. T., & Riddle, J. M. (1989) · Circulation Research · doi:10.1161/01.res.64.5.977 · Cited by 673
Sager, P. T., Gintant, G., Turner, J. R., Pettit, S., & Stockbridge, N. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.11.004 · Cited by 540
Self-citationEvolution of strategies to improve preclinical cardiac safety testing
Gintant, G., Sager, P. T., & Stockbridge, N. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.34 · Cited by 407
Self-citationBelardinelli, L., Shryock, J. C., & Fraser, H. (2006) · Heart · doi:10.1136/hrt.2005.078790 · Cited by 386
Crumb, W. J., Vicente, J., Johannesen, L., & Strauss, D. G. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.03.009 · Cited by 288
Self-citationJohannesen, L., Vicente, J., Mason, J. W., Sanabria, C., Waite-Labott, K., Hong, M., Guo, P., Lin, J., Sørensen, J. S., Galeotti, L., et al. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.155 · Cited by 254
Self-citationKirsch, G. E., Trepakova, E. S., Brimecombe, J. C., Sidach, S. S., Erickson, H. D., Kochan, M. C., Shyjka, L. M., Lacerda, A. E., & Brown, A. M. (2004) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2004.06.003 · Cited by 241
Harris, K., Aylott, M., Cui, Y., Louttit, J. B., McMahon, N. C., & Sridhar, A. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft113 · Cited by 227
Varró, A., & Baczkó, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01367.x · Cited by 207
Hayakawa, T., Kunihiro, T., Ando, T., Kobayashi, S., Matsui, E., Yada, H., Kanda, Y., Kurokawa, J., & Furukawa, T. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.010 · Cited by 198
Asakura, K., Hayashi, S., Ojima, A., Taniguchi, T., Miyamoto, N., Nakamori, C., Nagasawa, C., Kitamura, T., Osada, T., Honda, Y., et al. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.04.002 · Cited by 153
Self-citationClements, M., & Thomas, N. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu084 · Cited by 153
Johannesen, L., Vicente, J., Mason, J. W., Erato, C., Sanabria, C. R., Waite-Labott, K., Hong, M., Lin, J., Guo, P., Mutlib, A. E., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.205 · Cited by 152
Self-citationO’Hara, T., & Rudy, Y. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00785.2011 · Cited by 138
Lengyel, C., Varró, A., Tábori, K., Papp, J. G., & Baczkó, I. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707297 · Cited by 131
Vicente, J., Johannesen, L., Mason, J. W., Crumb, W., Pueyo, E., Stockbridge, N., & Strauss, D. G. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001615 · Cited by 123
Self-citationCerignoli, F., Charlot, D., Whittaker, R., Ingermanson, R., Gehalot, P., Savchenko, A., Gallacher, D. J., Towart, R., Price, J. H., McDonough, P. M., et al. (2012) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2012.08.167 · Cited by 114
A history of the role of the hERG channel in cardiac risk assessment
Rampe, D., & Brown, A. M. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.03.005 · Cited by 107
The electrophysiological development of cardiomyocytes
Liu, J., Laksman, Z., & Backx, P. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.023 · Cited by 106
Milnes, J. T., Witchel, H. J., Leaney, J. L., Leishman, D. J., & Hancox, J. C. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.02.007 · Cited by 101
van den Heuvel, N. H. L., van Veen, T. A. B., Lim, B., & Jonsson, M. K. B. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.011 · Cited by 93
Kitaguchi, T., Moriyama, Y., Taniguchi, T., Ojima, A., Ando, H., Uda, T., Otabe, K., Oguchi, M., Shimizu, S., Saito, H., et al. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.12.002 · Cited by 90
Lu, H. R., Whittaker, R., Price, J. H., Vega, R., Pfeiffer, E. R., Cerignoli, F., Towart, R., & Gallacher, D. J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv201 · Cited by 86
High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment
Veroli, G. Y. D., Davies, M. R., Zhang, H., Abi‐Gerges, N., & Boyett, M. R. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00511.2012 · Cited by 76
Nakamura, Y., Matsuo, J., Miyamoto, N., Ojima, A., Ando, K., Kanda, Y., Sawada, K., Sugiyama, A., & Sekino, Y. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13248fp · Cited by 76
Self-citationGilchrist, K. H., Lewis, G. F., Gay, E. A., Sellgren, K. L., & Grego, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.024 · Cited by 75
Veroli, G. Y. D., Davies, M. R., Zhang, H., Abi‐Gerges, N., & Boyett, M. R. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12289 · Cited by 70
Workman, A. J., Marshall, G., RANKIN, A. C., Smith, G. L., & Dempster, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.235986 · Cited by 62
Nozaki, Y., Honda, Y., Tsujimoto, S., Watanabe, H., Kunimatsu, T., & Funabashi, H. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.007 · Cited by 52
Uesugi, M., Ojima, A., Taniguchi, T., Miyamoto, N., & Sawada, K. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.11.002 · Cited by 47
Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates
Polak, S., Pugsley, M. K., Stockbridge, N., Garnett, C. E., & Wiśniowska, B. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9773-1 · Cited by 31
Self-citation
Cited by
The ‘Digital Twin’ to enable the vision of precision cardiology
Corral-Acero, J., Margara, F., Marciniak, M., Rodero, C., Loncaric, F., Feng, Y., Gilbert, A., Fernandes, J. F., Bukhari, H. A., Wajdan, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa159 · Cited by 932
Blinova, K., Dang, Q., Millard, D., Smith, G., Pierson, J., Guo, L., Brock, M., Lu, H. R., Kraushaar, U., Zeng, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.079 · Cited by 373
Self-citationPassini, E., Britton, O. J., Lu, H. R., Rohrbacher, J., Hermans, A. N., Gallacher, D. J., Greig, R. J. H., Bueno-Orovio, A., & Rodriguez, B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00668 · Cited by 326
Blinova, K., Stohlman, J., Vicente, J., Chan, D., Johannesen, L., Hortigon-Vinagre, M. P., Zamora, V., Smith, G., Crumb, W. J., Pang, L., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw200 · Cited by 272
Self-citationThe evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G., Hewitt, P., Mow, T., Oinonen, T., Roth, A., Steger-Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 255
Metadata
- Authors
- Colatsky, T., Fermini, B., Gintant, G., Pierson, J. B., Sager, P., Sekino, Y., Strauss, D. G., & Stockbridge, N.
- Venue
- Journal of Pharmacological and Toxicological Methods
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 81
- Pages
- 15-20
- ISSN
- 1056-8719 (ISSN-L)
- OpenAlex
- W2415670168
- Cited by
- 464
- References
- 35
- FWCI
- 44.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.